Ischemic stroke has become a major worldwide health problem due to its high recurrence and high disability and is getting increasing attention. Recent studies have shown that immune inflammation plays an important role in all aspects of stroke. This article reviews the progress in the research about the interaction between stroke and inflammatory cells and related antibodies, and the new target to prevent the progression of stroke with a view of providing more efficacious treatment for ischemic stroke.